Breaking News

Financial Report: Akorn

February 26, 2013

Achieves record 4Q and FY revenue


4Q Revenues: $71.5 million (+68%)

4Q Earnings: $8.8 million  (+54%)

FY Revenues: $256.2 million (+87%)

FY Earnings: $35.4 million (-18%)

Comments: Growth in the quarter and FY was driven by the Lundbeck and Kilitch acquisitions, the sale of newly approved and re-launched products, and growth of established products, offset by decreases in the U.S. contract services business.
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments